Results
|
|
1661.
|
|
|
|
1662.
|
|
|
|
1663.
|
Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006). [electronic resource] by
- Schachter, Jacob
- Ribas, Antoni
- Long, Georgina V
- Arance, Ana
- Grob, Jean-Jacques
- Mortier, Laurent
- Daud, Adil
- Carlino, Matteo S
- McNeil, Catriona
- Lotem, Michal
- Larkin, James
- Lorigan, Paul
- Neyns, Bart
- Blank, Christian
- Petrella, Teresa M
- Hamid, Omid
- Zhou, Honghong
- Ebbinghaus, Scot
- Ibrahim, Nageatte
- Robert, Caroline
Producer: 20180927
In:
Lancet (London, England) vol. 390
Availability: No items available.
|
|
|
1664.
|
|
|
|
1665.
|
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series. [electronic resource] by
- Moseley, Kendall F
- Naidoo, Jarushka
- Bingham, Clifton O
- Carducci, Michael A
- Forde, Patrick M
- Gibney, Geoffrey T
- Lipson, Evan J
- Shah, Ami A
- Sharfman, William H
- Cappelli, Laura C
Producer: 20191016
In:
Journal for immunotherapy of cancer vol. 6
Availability: No items available.
|
|
|
1666.
|
Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer. [electronic resource] by
- Chu, Jacqueline N
- Choi, Jin
- Ostvar, Sassan
- Torchia, James A
- Reynolds, Kerry Lynn
- Tramontano, Angela
- Gainor, Justin F
- Chung, Daniel C
- Clark, Jeffrey W
- Hur, Chin
Producer: 20191024
In:
Cancer vol. 125
Availability: No items available.
|
|
|
1667.
|
|
|
|
1668.
|
|
|
|
1669.
|
Immunity to X-linked inhibitor of apoptosis protein (XIAP) in malignant melanoma and check-point blockade. [electronic resource] by
- Zhou, Jun
- Li, Jingjing
- Guleria, Indira
- Chen, Tianqi
- Giobbie-Hurder, Anita
- Stevens, Jonathan
- Gupta, Meghna
- Wu, Xinqi
- Brennick, Ryan C
- Manos, Michael P
- Hodi, F Stephen
Producer: 20190813
In:
Cancer immunology, immunotherapy : CII vol. 68
Availability: No items available.
|
|
|
1670.
|
|
|
|
1671.
|
|
|
|
1672.
|
|
|
|
1673.
|
|
|
|
1674.
|
|
|
|
1675.
|
|
|
|
1676.
|
|
|
|
1677.
|
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma. [electronic resource] by
- Geoerger, Birgit
- Bergeron, Christophe
- Gore, Lia
- Sender, Leonard
- Dunkel, Ira J
- Herzog, Cynthia
- Brochez, Lieve
- Cruz, Ofelia
- Nysom, Karsten
- Berghorn, Elmer
- Simsek, Burcin
- Shen, Jun
- Pappo, Alberto
Producer: 20171121
In:
European journal of cancer (Oxford, England : 1990) vol. 86
Availability: No items available.
|
|
|
1678.
|
U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab. [electronic resource] by
- Hazarika, Maitreyee
- Chuk, Meredith K
- Theoret, Marc R
- Mushti, Sirisha
- He, Kun
- Weis, Shawna L
- Putman, Alexander H
- Helms, Whitney S
- Cao, Xianhua
- Li, Hongshan
- Zhao, Hong
- Zhao, Liang
- Welch, Joel
- Graham, Laurie
- Libeg, Meredith
- Sridhara, Rajeshwari
- Keegan, Patricia
- Pazdur, Richard
Producer: 20180601
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 23
Availability: No items available.
|
|
|
1679.
|
|
|
|
1680.
|
|